한국인 좌심실 비대증 환자들에서 파브리병 선별검사의 의의 |
Park, Hyeong-Du
(성균관의대 삼성서울병원 진단검사의학과)
Jo, Seong-Yun (성균관의대 삼성서울병원 소아청소년과) Lee, Su-Yeon (성균관의대 삼성서울병원 진단검사의학과) Jeon, Eun-Seok (성균관의대 삼성서울병원 내과) Park, Seung-U (성균관의대 삼성서울병원 내과) Lee, Sang-Hun (성균관의대 삼성서울병원 내과) Lee, Sang-Cheol (성균관의대 삼성서울병원 내과) Choe, Jin-O (성균관의대 삼성서울병원 내과) Park, Seong-Ji (성균관의대 삼성서울병원 내과) Jang, Seong-A (성균관의대 삼성서울병원 내과) Kim, Hyeong-Gwan (서울대학교병원 내과) Gi, Chang-Seok (성균관의대 삼성서울병원 진단검사의학과) Kim, Jong-Won (성균관의대 삼성서울병원 진단검사의학과) Jin, Dong-Gyu (성균관의대 삼성서울병원 소아청소년과) |
1 | Auray-Blais C, Cyr D, Mills K, Giguere R, Drouin R. Development of a filter paper method potentially applicable to mass and high-risk urinary screenings for Fabry disease. J Inherit Metab Dis 2007;30:106. DOI |
2 | Senechal M and Germain DP. Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients. Clin Genet 2003;63:46-52. |
3 | Mehta A, Clarke JT, Giugliani R, Elliott P, Linhart A, Beck M, et al. Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet 2009;46:548-52. DOI ScienceOn |
4 | Linthorst GE, Bouwman MG, Wijburg FA, Aerts JM, Poorthuis BJ, Hollak CE. Screening for Fabry disease in high-risk populations: a systematic review. J Med Genet 2010;47:217-22. DOI |
5 | Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995;333:288-93. DOI ScienceOn |
6 | Rolfs A, Bottcher T, Zschiesche M, Morris P, Winchester B, Bauer P, et al. Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study. Lancet 2005;366:1794-6. DOI ScienceOn |
7 | Lv YL, Wang WM, Pan XX, Wang ZH, Chen N, Ye ZY, et al. A successful screening for Fabry disease in a Chinese dialysis patient population. Clin Genet 2009;76:219-21. DOI ScienceOn |
8 | Germain DP, Weidemann F, Abiose A, Patel MR, Cizmarik M, Cole JA, et al. Analysis of left ventricular mass in untreated men and in men treated with agalsidase-beta: data from the Fabry Registry. Genet Med 2013;15:958-65. DOI ScienceOn |
9 | Kruger R, Bruns K, Grunhage S, Rossmann H, Reinke J, Beck M, et al. Determination of globotriaosylceramide in plasma and urine by mass spectrometry. Clin Chem Lab Med 2010;48:189-98. |
10 | Paschke E, Fauler G, Winkler H, Schlagenhauf A, Plecko B, Erwa W, et al. Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study. Am J Kidney Dis 2011;57:673-81. DOI ScienceOn |
11 | Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet 2006;79:31-40. DOI ScienceOn |
12 | Wang RY, Lelis A, Mirocha J, Wilcox WR. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 2007;9:34-45. DOI ScienceOn |
13 | Sokolow M and Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37:161-86. DOI ScienceOn |
14 | Clarke JT. Narrative review: Fabry disease. Ann Intern Med 2007;146:425-33. DOI ScienceOn |
15 | MacDermot KD, Holmes A, Miners AH. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 2001;38:750-60. DOI |
16 | Beer G, Reinecke P, Gabbert HE, Hort W, Kuhn H. Fabry disease in patients with hypertrophic cardiomyopathy (HCM). Z Kardiol 2002;91:992-1002. DOI ScienceOn |
17 | Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. Circulation 1987;75:565-72. DOI ScienceOn |